Clinician beliefs and attitudes about buprenorphine/naloxone diversion

Am J Addict. 2013 Nov-Dec;22(6):574-80. doi: 10.1111/j.1521-0391.2013.12024.x. Epub 2013 Apr 11.

Abstract

Background and objectives: Concern about diversion of buprenorphine/naloxone (B/N) in the United States may affect prescribing patterns and policy decisions. This study examines addiction treatment clinician beliefs and attitudes regarding B/N diversion.

Methods: Participants (n = 369) completed a 34-item survey in 2010 during two national symposia on opioid dependence. We conducted multivariable regression, examining the relationship of perceived danger from B/N diversion with clinician characteristics and their beliefs about B/N treatment and diversion. We compared causal beliefs about diversion among clinicians with and without B/N treatment experience.

Results: Forty percent of clinicians believed that B/N diversion is a dangerous problem. The belief that B/N diversion increases accidental overdoses in the community was strongly associated with perceived danger from B/N diversion.

Conclusions and scientific significance: Attitudes and beliefs, not education level, were associated with clinician's perceived danger from B/N diversion. Clinicians with greater B/N patient experience were more likely to believe treatment access barriers are the major cause of B/N diversion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analgesics, Opioid*
  • Attitude of Health Personnel*
  • Buprenorphine*
  • Buprenorphine, Naloxone Drug Combination
  • Drug Overdose / prevention & control
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Naloxone*
  • Opiate Substitution Treatment*
  • Practice Patterns, Physicians'*
  • Prescription Drug Diversion*
  • Regression Analysis
  • United States

Substances

  • Analgesics, Opioid
  • Buprenorphine, Naloxone Drug Combination
  • Naloxone
  • Buprenorphine